COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
September 2013

30

September
2013

category:

503b Compounding

Congress, FDA playing blame game on outbreak

A year of finger-pointing Congress and the U.S. Food and Drug Administration culminated last week in the introduction of legislation that would give the FDA greater oversight over larger compounding pharmacies. The bill was negotiated between the House and Senate and was announced Wednesday, a year after the first cases of fungal meningitis linked to […]

read more

30

September
2013

category:

503b Compounding

Today’s Shortages

ASHP/FDA   Calcium Chloride Injection Doxorubicin Liposomal Injection Potassium Phosphate Injection

read more

29

September
2013

category:

503b Compounding

Drug Safety Bill Approved By House In Bipartisan Fashion

WASHINGTON — The House easily approved bipartisan legislation Saturday aimed at improving the safety of drugs produced by compounding pharmacies that mix customized pharmaceuticals. The measure, approved on a voice vote, comes almost a year after a meningitis outbreak that killed 64 people and sickened hundreds more was traced to a compounding company in Framingham, […]

read more